Sayre Therapeutics Overview
Founded
2015
Status
Private
Latest Deal Type
Early Stage VC
Latest Deal Amount
$4M
Investors
2
Sayre Therapeutics General Information
Description
Developer of a drug development platform designed to specialize in treating cancer and immunity related diseases. The company's platform facilitates development and registration of novel drugs, drug-delivery devices and companion diagnostics, enabling pharmaceutical companies to commercialize proprietary drugs and medicines for the treatment of cancer.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Number 91, 3rd Floor, GR Square
- Amar Jyothi Nagar HBCS Layout, Inner Ring road, Domlur
- Bangalore, Karnataka 560071
- India
+91 080 0000 0000
Sayre Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 04-Sep-2017 | $4M | 000 | Completed | Startup | |
| 1. Early Stage VC (Series A) | 07-Apr-2015 | 000 | 000 | Completed | Startup |
Sayre Therapeutics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Shukrit Chimote | Co-Founder & Chief Executive Officer |
1 Former Executive
Sayre Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Aarin Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Accel | Venture Capital | Minority | 000 0000 | 000000 0 |
Ready to get started?
Request a free trial